In a history-making moment for WM patients, the IWMF is pleased to announce that Imbruvica (ibrutinib) has just received FDA approval specifically for the...
View rebroadcasts from the October 6th 2021 Ed Forum WM Basics Workshop and NEW Q&A with our presenters! Please note that you will need to register to view the live and on demand webcasts.
Getting a diagnosis of WM can feel overwhelming. You have questions, we have answers! Tap in to our comprehensive resources about this rare disease.
We are here to support you throughout your journey living with Waldenstrom macroglobulinemia. Remember, with the IWMF, you are never alone.
When you join the IWMF, you become a member of an international community of people affected by Waldenstrom macroglobulinemia.
Day(s)
:
Hour(s)
:
Minute(s)
:
Second(s)
In a history-making moment for WM patients, the IWMF is pleased to announce that Imbruvica (ibrutinib) has just received FDA approval specifically for the...
“Waldenstrom’s and MGUS in Families: Your Questions and Answers.” Dr. Mary Lou McMaster of NIH discusses WM biology and treatments and...
We are pleased to announce the establishment in Italy of an IWMF Affiliate/Support Group under the sponsorship of Dr. Enrica Morra, President of Associazione...